Annual Net Income
-$24.02 M
+$16.99 M+41.43%
31 December 2023
Summary:
Trinity Biotech annual net profit is currently -$24.02 million, with the most recent change of +$16.99 million (+41.43%) on 31 December 2023. During the last 3 years, it has fallen by -$17.63 million (-275.99%). TRIB annual net income is now -139.75% below its all-time high of $60.42 million, reached on 31 December 2010.TRIB Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$4.76 M
+$2.00 M+29.57%
30 September 2024
Summary:
Trinity Biotech quarterly net profit is currently -$4.76 million, with the most recent change of +$2.00 million (+29.57%) on 30 September 2024. Over the past year, it has increased by +$1.96 million (+29.19%). TRIB quarterly net income is now -109.39% below its all-time high of $50.68 million, reached on 30 June 2010.TRIB Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$20.33 M
+$1.96 M+8.80%
30 September 2024
Summary:
Trinity Biotech TTM net profit is currently -$20.33 million, with the most recent change of +$1.96 million (+8.80%) on 30 September 2024. Over the past year, it has increased by +$8.26 million (+28.89%). TRIB TTM net income is now -133.33% below its all-time high of $61.01 million, reached on 31 March 2011.TRIB TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRIB Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +41.4% | +29.2% | +28.9% |
| 3 y3 years | -276.0% | -460.3% | -157.9% |
| 5 y5 years | -8.7% | -10000.0% | +31.2% |
TRIB Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2844.9% | +41.4% | -460.3% | +61.2% | -2423.9% | +50.4% |
| 5 y | 5 years | -2844.9% | +41.4% | -165.0% | +79.6% | -2423.9% | +50.4% |
| alltime | all time | -139.8% | +76.1% | -109.4% | +95.3% | -133.3% | +79.8% |
Trinity Biotech Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$4.76 M(-29.6%) | -$20.33 M(-8.8%) |
| June 2024 | - | -$6.76 M(+103.7%) | -$22.30 M(+3.6%) |
| Mar 2024 | - | -$3.32 M(-39.7%) | -$21.53 M(-10.4%) |
| Dec 2023 | -$24.02 M(-41.4%) | -$5.50 M(-18.2%) | -$24.02 M(-16.0%) |
| Sept 2023 | - | -$6.72 M(+12.2%) | -$28.60 M(-7.2%) |
| June 2023 | - | -$5.99 M(+3.1%) | -$30.82 M(-10.8%) |
| Mar 2023 | - | -$5.81 M(-42.4%) | -$34.54 M(-15.8%) |
| Dec 2022 | -$41.01 M(-4786.7%) | -$10.08 M(+12.7%) | -$41.01 M(+27.4%) |
| Sept 2022 | - | -$8.95 M(-7.8%) | -$32.20 M(+46.8%) |
| June 2022 | - | -$9.71 M(-21.0%) | -$21.93 M(+68.6%) |
| Mar 2022 | - | -$12.28 M(+870.7%) | -$13.01 M(-1586.4%) |
| Dec 2021 | $875.00 K(-113.7%) | -$1.26 M(-195.8%) | $875.00 K(-111.1%) |
| Sept 2021 | - | $1.32 M(-268.7%) | -$7.88 M(+319.4%) |
| June 2021 | - | -$783.00 K(-148.9%) | -$1.88 M(-26.7%) |
| Mar 2021 | - | $1.60 M(-116.0%) | -$2.56 M(-59.9%) |
| Dec 2020 | -$6.39 M(-77.9%) | -$10.02 M(-236.8%) | -$6.39 M(-67.6%) |
| Sept 2020 | - | $7.33 M(-599.3%) | -$19.69 M(-27.1%) |
| June 2020 | - | -$1.47 M(-34.0%) | -$26.99 M(-12.7%) |
| Mar 2020 | - | -$2.22 M(-90.5%) | -$30.93 M(+7.0%) |
| Dec 2019 | -$28.91 M(+30.9%) | -$23.32 M(<-9900.0%) | -$28.91 M(-2.1%) |
| Sept 2019 | - | $25.00 K(-100.5%) | -$29.55 M(+3.0%) |
| June 2019 | - | -$5.41 M(+2461.6%) | -$28.68 M(+26.5%) |
| Mar 2019 | - | -$211.00 K(-99.1%) | -$22.68 M(+2.7%) |
| Dec 2018 | -$22.09 M(-45.1%) | -$23.96 M(-2773.9%) | -$22.09 M(-46.1%) |
| Sept 2018 | - | $896.00 K(+50.8%) | -$40.99 M(-1.1%) |
| June 2018 | - | $594.00 K(+57.1%) | -$41.45 M(+0.7%) |
| Mar 2018 | - | $378.00 K(-100.9%) | -$41.14 M(+2.2%) |
| Dec 2017 | -$40.27 M(-60.0%) | -$42.86 M(-9732.1%) | -$40.27 M(-59.0%) |
| Sept 2017 | - | $445.00 K(-50.7%) | -$98.27 M(-1.0%) |
| June 2017 | - | $902.00 K(-27.6%) | -$99.23 M(+1.2%) |
| Mar 2017 | - | $1.25 M(-101.2%) | -$98.03 M(-2.6%) |
| Dec 2016 | -$100.63 M(-561.7%) | -$100.87 M(>+9900.0%) | -$100.63 M(-3382.0%) |
| Sept 2016 | - | -$517.00 K(-124.6%) | $3.07 M(-80.7%) |
| June 2016 | - | $2.10 M(-256.2%) | $15.85 M(-3.6%) |
| Mar 2016 | - | -$1.35 M(-147.7%) | $16.44 M(-24.6%) |
| Dec 2015 | $21.80 M(+26.6%) | $2.83 M(-77.0%) | $21.79 M(-5.6%) |
| Sept 2015 | - | $12.26 M(+355.2%) | $23.09 M(+52.0%) |
| June 2015 | - | $2.69 M(-32.8%) | $15.19 M(-9.6%) |
| Mar 2015 | - | $4.01 M(-2.8%) | $16.81 M(-2.4%) |
| Dec 2014 | $17.21 M(+78.5%) | $4.13 M(-5.4%) | $17.21 M(-2.9%) |
| Sept 2014 | - | $4.36 M(+1.1%) | $17.73 M(+70.8%) |
| June 2014 | - | $4.32 M(-2.2%) | $10.38 M(+4.9%) |
| Mar 2014 | - | $4.41 M(-4.9%) | $9.89 M(+2.5%) |
| Dec 2013 | $9.65 M(-44.4%) | $4.64 M(-255.2%) | $9.65 M(+1.8%) |
| Sept 2013 | - | -$2.99 M(-178.1%) | $9.48 M(-44.0%) |
| June 2013 | - | $3.83 M(-8.2%) | $16.93 M(-2.7%) |
| Mar 2013 | - | $4.17 M(-6.7%) | $17.40 M(+0.3%) |
| Dec 2012 | $17.34 M(+11.2%) | $4.47 M(+0.2%) | $17.34 M(+2.5%) |
| Sept 2012 | - | $4.46 M(+3.7%) | $16.92 M(+3.2%) |
| June 2012 | - | $4.30 M(+4.7%) | $16.39 M(+2.8%) |
| Mar 2012 | - | $4.11 M(+1.6%) | $15.95 M(+2.3%) |
| Dec 2011 | $15.59 M(-74.2%) | $4.04 M(+2.8%) | $15.59 M(+2.5%) |
| Sept 2011 | - | $3.94 M(+1.9%) | $15.21 M(+7.2%) |
| June 2011 | - | $3.86 M(+2.9%) | $14.19 M(-76.7%) |
| Mar 2011 | - | $3.75 M(+2.5%) | $61.01 M(+1.0%) |
| Dec 2010 | $60.42 M(+411.0%) | $3.66 M(+25.4%) | $60.42 M(+0.7%) |
| Sept 2010 | - | $2.92 M(-94.2%) | $60.02 M(-0.2%) |
| June 2010 | - | $50.68 M(+1505.4%) | $60.15 M(+382.1%) |
| Mar 2010 | - | $3.16 M(-3.1%) | $12.48 M(+5.5%) |
| Dec 2009 | $11.82 M | $3.26 M(+6.6%) | $11.82 M(-116.2%) |
| Sept 2009 | - | $3.06 M(+1.7%) | -$73.09 M(-2.3%) |
| June 2009 | - | $3.00 M(+20.0%) | -$74.83 M(-2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2009 | - | $2.50 M(-103.1%) | -$76.32 M(-1.9%) |
| Dec 2008 | -$77.78 M(+119.9%) | -$81.66 M(-6281.5%) | -$77.78 M(-2105.1%) |
| Sept 2008 | - | $1.32 M(-12.5%) | $3.88 M(-114.1%) |
| June 2008 | - | $1.51 M(+43.9%) | -$27.59 M(+4.2%) |
| Mar 2008 | - | $1.05 M(>+9900.0%) | -$26.48 M(+7.6%) |
| Dec 2007 | -$35.37 M(-1179.7%) | $0.00(-100.0%) | -$24.62 M(+6.9%) |
| Sept 2007 | - | -$30.15 M(-1253.3%) | -$23.02 M(-338.0%) |
| June 2007 | - | $2.61 M(-10.2%) | $9.67 M(+95.5%) |
| Mar 2007 | - | $2.91 M(+82.2%) | $4.95 M(+51.0%) |
| Dec 2006 | $3.28 M(-38.0%) | $1.60 M(-37.4%) | $3.28 M(-7.6%) |
| Sept 2006 | - | $2.55 M(-220.8%) | $3.55 M(+42.6%) |
| June 2006 | - | -$2.11 M(-270.5%) | $2.49 M(-56.2%) |
| Mar 2006 | - | $1.24 M(-33.7%) | $5.68 M(+4.3%) |
| Dec 2005 | $5.28 M(-7.6%) | $1.87 M(+25.2%) | $5.45 M(-7.2%) |
| Sept 2005 | - | $1.49 M(+37.8%) | $5.87 M(-0.2%) |
| June 2005 | - | $1.08 M(+8.0%) | $5.88 M(-2.1%) |
| Mar 2005 | - | $1.00 M(-56.3%) | $6.01 M(+5.2%) |
| Dec 2004 | $5.71 M(-1.4%) | $2.29 M(+52.5%) | $5.71 M(+44.2%) |
| Sept 2004 | - | $1.50 M(+24.2%) | $3.96 M(-7.1%) |
| June 2004 | - | $1.21 M(+71.3%) | $4.27 M(-11.3%) |
| Mar 2004 | - | $707.00 K(+30.9%) | $4.81 M(-17.0%) |
| Dec 2003 | $5.80 M(+18.4%) | $540.00 K(-70.1%) | $5.80 M(-12.8%) |
| Sept 2003 | - | $1.81 M(+3.0%) | $6.65 M(+11.1%) |
| June 2003 | - | $1.76 M(+3.8%) | $5.98 M(+11.7%) |
| Mar 2003 | - | $1.69 M(+21.6%) | $5.36 M(+9.4%) |
| Dec 2002 | $4.90 M(+106.9%) | $1.39 M(+21.6%) | $4.90 M(+77.2%) |
| Sept 2002 | - | $1.15 M(+1.4%) | $2.76 M(+1.0%) |
| June 2002 | - | $1.13 M(-8.3%) | $2.74 M(+4.6%) |
| Mar 2002 | - | $1.23 M(-266.0%) | $2.61 M(+10.4%) |
| Dec 2001 | $2.37 M(-50.9%) | -$741.70 K(-166.4%) | $2.37 M(-25.9%) |
| Sept 2001 | - | $1.12 M(+10.8%) | $3.20 M(-16.2%) |
| June 2001 | - | $1.01 M(+2.4%) | $3.81 M(-13.5%) |
| Mar 2001 | - | $984.00 K(+1037.6%) | $4.41 M(-8.6%) |
| Dec 2000 | $4.82 M(-1.9%) | $86.50 K(-95.0%) | $4.82 M(-25.2%) |
| Sept 2000 | - | $1.74 M(+8.3%) | $6.45 M(+9.0%) |
| June 2000 | - | $1.60 M(+14.3%) | $5.92 M(+9.3%) |
| Mar 2000 | - | $1.40 M(-18.3%) | $5.42 M(+10.2%) |
| Dec 1999 | $4.92 M(+89.1%) | $1.72 M(+43.0%) | $4.92 M(+19.9%) |
| Sept 1999 | - | $1.20 M(+9.1%) | $4.10 M(+13.9%) |
| June 1999 | - | $1.10 M(+22.2%) | $3.60 M(+16.1%) |
| Mar 1999 | - | $900.00 K(0.0%) | $3.10 M(+14.8%) |
| Dec 1998 | $2.60 M(+116.7%) | $900.00 K(+28.6%) | $2.70 M(+22.7%) |
| Sept 1998 | - | $700.00 K(+16.7%) | $2.20 M(+15.8%) |
| June 1998 | - | $600.00 K(+20.0%) | $1.90 M(+18.8%) |
| Mar 1998 | - | $500.00 K(+25.0%) | $1.60 M(+23.1%) |
| Dec 1997 | $1.20 M(-233.3%) | $400.00 K(0.0%) | $1.30 M(+44.4%) |
| Sept 1997 | - | $400.00 K(+33.3%) | $900.00 K(+80.0%) |
| June 1997 | - | $300.00 K(+50.0%) | $500.00 K(+150.0%) |
| Mar 1997 | - | $200.00 K(-166.7%) | $200.00 K(-125.0%) |
| Dec 1996 | -$900.00 K(+12.5%) | - | - |
| Dec 1995 | -$800.00 K(-75.8%) | -$300.00 K(+200.0%) | -$800.00 K(+60.0%) |
| Sept 1995 | - | -$100.00 K(0.0%) | -$500.00 K(-66.7%) |
| June 1995 | - | -$100.00 K(-66.7%) | -$1.50 M(-40.0%) |
| Mar 1995 | - | -$300.00 K(-72.7%) | -$2.50 M(-34.2%) |
| Dec 1994 | -$3.30 M(-2.9%) | - | - |
| Aug 1994 | - | -$1.10 M(0.0%) | -$3.80 M(+5.6%) |
| May 1994 | - | -$1.10 M(+57.1%) | -$3.60 M(+5.9%) |
| Feb 1994 | - | -$700.00 K(-22.2%) | -$3.40 M(+25.9%) |
| Feb 1994 | -$3.40 M | - | - |
| Nov 1993 | - | -$900.00 K(0.0%) | -$2.70 M(+50.0%) |
| Aug 1993 | - | -$900.00 K(0.0%) | -$1.80 M(+100.0%) |
| May 1993 | - | -$900.00 K | -$900.00 K |
FAQ
- What is Trinity Biotech annual net profit?
- What is the all time high annual net income for Trinity Biotech?
- What is Trinity Biotech annual net income year-on-year change?
- What is Trinity Biotech quarterly net profit?
- What is the all time high quarterly net income for Trinity Biotech?
- What is Trinity Biotech quarterly net income year-on-year change?
- What is Trinity Biotech TTM net profit?
- What is the all time high TTM net income for Trinity Biotech?
- What is Trinity Biotech TTM net income year-on-year change?
What is Trinity Biotech annual net profit?
The current annual net income of TRIB is -$24.02 M
What is the all time high annual net income for Trinity Biotech?
Trinity Biotech all-time high annual net profit is $60.42 M
What is Trinity Biotech annual net income year-on-year change?
Over the past year, TRIB annual net profit has changed by +$16.99 M (+41.43%)
What is Trinity Biotech quarterly net profit?
The current quarterly net income of TRIB is -$4.76 M
What is the all time high quarterly net income for Trinity Biotech?
Trinity Biotech all-time high quarterly net profit is $50.68 M
What is Trinity Biotech quarterly net income year-on-year change?
Over the past year, TRIB quarterly net profit has changed by +$1.96 M (+29.19%)
What is Trinity Biotech TTM net profit?
The current TTM net income of TRIB is -$20.33 M
What is the all time high TTM net income for Trinity Biotech?
Trinity Biotech all-time high TTM net profit is $61.01 M
What is Trinity Biotech TTM net income year-on-year change?
Over the past year, TRIB TTM net profit has changed by +$8.26 M (+28.89%)